Prahalada holds a Ph.D in Comparative Pathology and MS in Anatomy from the University of California and a Bachelor’s degree in Veterinary Medicine from the University of Agricultural Sciences, Bangalore. Prior to joining Syngene in 2016, he was working with Merck and Company (MSD) for over 28 years during which period he moved up the ranks to become the Head of Pathology in Safety Assessment. He was responsible for preclinical development of many compounds which resulted in successful registration globally. He was also the Head of Pathology at the Regional Primate Center, University of California, Davis for 3 years. Dr Prahalada has an impressive list of scientific publications in peer-reviewed journals in the areas of developmental pathology, anatomic pathology, toxicology and reproductive endocrinology.